Early intervention for lifetime CV risk reduction
Clinical updates in management of cardiovascular risk (1/4)
CV risk factors that drive arterial disease in early life have a major impact on future CV risk. Communication about early lifestyle intervention to the public should be a major focus to reduce CV risk in later years.
Video navigation menu
- Accumulation of atherosclerosis during pre-clinical phase has a major impact future CV risk 1:00
- Exposure to risk factors over life drives future CV outcomes 4:55
- Communicate the idea of intervention during early life to patients and public 6:48
- CV factors in early life drive cognitive decline in later years 11:02
- How early should prevention start? 12:24
This educational video is part of a series of 4 videos with the theme: Clinical Updates in Management of Cardiovascular Risk.
Educational objectives are:
- To review the epidemiology and current guidelines on the diagnosis, management, and treatment of patients at increased CV risk
- To understand the medical need for intensive risk interventions in patients at high CV risk, including diabetes
- To discuss new concepts in cardiovascular risk management including earlier and more intensive intervention and integrate scientific evidence from key clinical trials into practice
- To explore the role of new risk calculation models for cardiovascular risk estimation and communication
Prof. John E Deanfield, MD is Professor of Cardiology, Director, National Centre for Cardiovascular Prevention and Outcomes, University College London, United Kingdom
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Funding for this educational program was provided by an unrestricted educational grant from Pfizer
This is available as accredited online CME for members. Click the button below to enroll:Enroll